GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (NYSE:EW) » Definitions » Cyclically Adjusted PS Ratio

EW (Edwards Lifesciences) Cyclically Adjusted PS Ratio : 9.79 (As of May. 20, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted PS Ratio?

As of today (2025-05-20), Edwards Lifesciences's current share price is $77.83. Edwards Lifesciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $7.95. Edwards Lifesciences's Cyclically Adjusted PS Ratio for today is 9.79.

The historical rank and industry rank for Edwards Lifesciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

EW' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 8.13   Med: 13.33   Max: 23.68
Current: 9.82

During the past years, Edwards Lifesciences's highest Cyclically Adjusted PS Ratio was 23.68. The lowest was 8.13. And the median was 13.33.

EW's Cyclically Adjusted PS Ratio is ranked worse than
86.46% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 2.2 vs EW: 9.82

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Edwards Lifesciences's adjusted revenue per share data for the three months ended in Mar. 2025 was $2.403. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $7.95 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Edwards Lifesciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted PS Ratio Chart

Edwards Lifesciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.16 22.91 11.66 10.76 9.58

Edwards Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.04 12.34 8.67 9.58 9.12

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted PS Ratio falls into.


;
;

Edwards Lifesciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Edwards Lifesciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=77.83/7.95
=9.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Edwards Lifesciences's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.403/134.9266*134.9266
=2.403

Current CPI (Mar. 2025) = 134.9266.

Edwards Lifesciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.935 100.684 1.253
201509 0.933 100.392 1.254
201512 1.013 99.792 1.370
201603 1.067 100.470 1.433
201606 1.165 101.688 1.546
201609 1.130 101.861 1.497
201612 1.173 101.863 1.554
201703 1.361 102.862 1.785
201706 1.301 103.349 1.699
201709 1.267 104.136 1.642
201712 1.376 104.011 1.785
201803 1.387 105.290 1.777
201806 1.470 106.317 1.866
201809 1.417 106.507 1.795
201812 1.536 105.998 1.955
201903 1.560 107.251 1.963
201906 1.708 108.070 2.132
201909 1.719 108.329 2.141
201912 1.841 108.420 2.291
202003 1.777 108.902 2.202
202006 1.491 108.767 1.850
202009 1.808 109.815 2.221
202012 1.859 109.897 2.282
202103 1.927 111.754 2.327
202106 2.184 114.631 2.571
202109 2.074 115.734 2.418
202112 2.105 117.630 2.415
202203 2.131 121.301 2.370
202206 2.192 125.017 2.366
202209 2.112 125.227 2.276
202212 0.698 125.222 0.752
202303 2.389 127.348 2.531
202306 2.123 128.729 2.225
202309 2.040 129.860 2.120
202312 2.086 129.419 2.175
202403 2.201 131.776 2.254
202406 2.293 132.554 2.334
202409 2.265 133.029 2.297
202412 2.346 133.157 2.377
202503 2.403 134.927 2.403

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Edwards Lifesciences  (NYSE:EW) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Edwards Lifesciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Executives
Bobo Donald E Jr officer: CVP,Strategy/Corp Development C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE CA 92614
Scott B. Ullem officer: CVP, CFO C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Bernard J Zovighian officer: CVP, Surgical Heart Valves C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Steven R Loranger director XYLEM. INC., 1133 WESTCHESTER AVENUE, WHITE PLAINS NY 10604
Heisz Leslie Stone director C/O PUBLIC STORAGE, 701 WESTERN AVENUE, GLENDALE CA 91201
Wayne Markowitz officer: GM & SVP, Surgical ONE EDWARDS WAY, IRVINE CA 92614
Daveen Chopra officer: CVP, Surgical Structural Heart C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92618
Larry L Wood officer: CVP, THV Replacement C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Michael A Mussallem director, officer: Chairman & CEO C/O EDWARDS LIFESCIENCES CORP, ONE EDWARDS WAY, IRVINE CA 92614
Jean-luc M Lemercier officer: CVP, EMEA, Canada, Latin Amer C/O ONE EDWARDS WAY, IRVINE CA 92614
Kieran Gallahue director PO BOX 684369, PARK CITY UT 84068
Catherine M. Szyman officer: CVP, Critical Care C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Sellers Robert W.a. officer: VP, Corp. Controller (Principa ONE EDWARDS WAY, IRVINE CA 92614
Huimin Wang officer: CVP, Japan & Intercontinental C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE CA 92614
Martha H. Marsh director 9769 WEXFORD CIRCLE, GRANITE BAY CA 95746